sabrina trial: subcutaneous versus intravenous rituximab for follicular lymphoma
Published 9 years ago • 153 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
10:41
trial updates in follicular lymphoma from ash 2019
-
2:21
the shine trial: controversies and unanswered questions
-
1:45
momelotinib vs soc in patients with mf and anemia: an analysis from the simplify-2 trial
-
1:43
first results of the apollo trial: atra-ato versus soc in high-risk acute promyelocytic leukemia
-
2:31
a subgroup analysis of the secombit trial
-
1:51
unmet needs in follicular lymphoma
-
1:38
challenges with the identification of all subtypes
-
0:43
challenges with single-cell multi-omics studies for wm: selecting genes for flow cytometry
-
5:21
chemo-free regimens in lymphoma
-
2:53
women in lymphoma
-
1:17
the evolution of frontline treatment for cll: from chemoimmunotherapy to targeted agents
-
1:54
defining lymphoma reservoirs
-
1:12
the key unmet needs in the frontline and r/r setting in amyloidosis
-
1:04
the current limitations of mouse models of cll: moving towards humanized models
-
1:23
the importance of myeloma-specific frailty indices in trial design
-
2:41
gray zone lymphoma: pembrolizumab
-
2:06
josé baselga: cancer’s fiercest opponent - official trailer
-
2:38
insights from the uptider program in metastatic breast cancer
-
1:51
evolving treatment paradigms in metastatic breast cancer